Direct interaction between Myocyte Enhancer Factor 2 (MEF2) and protein phosphatase 1α represses MEF2-dependent gene expression

Molecular and Cellular Biology

Volumn 29, Issue 12, 2009, Pages 3355-3366

  Perry, R L S ^a   Yang, C ^a,b   Soora, N ^a   Salma, J ^a   Marback, M ^a   Naghibi, L ^a   Ilyas, H ^a   Chan, J ^a   Gordon, J W ^a   McDermott, J C ^a  

^a YORK UNIVERSITY   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; HISTONE DEACETYLASE 4; MYOCYTE ENHANCER FACTOR 2; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 1 ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME REPRESSION; GENE EXPRESSION; GENE INTERACTION; HIPPOCAMPUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; GENE EXPRESSION; HELA CELLS; HUMANS; MADS DOMAIN PROTEINS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MYOGENIC REGULATORY FACTORS; NEURONS; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN PHOSPHATASE 1; RATS; RECOMBINANT FUSION PROTEINS;

EID: 67649195208     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00227-08     Document Type: Article

References (61)

1. 2+ and cAMP on transcription mediated by MEF2D and cAMP-response element-binding protein in hippocampal neurons. J. Biol. Chem. 281:27724-27732.
2. 1 arrest in human cancer cells. Curr. Biol. 7:375-386.
3. Black, B. L., and E. N. Olson. 1998. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 14:167-196.
4. 2+-dependent gene expression mediated by MEF2 transcription factors. J. Biol. Chem. 275:197-209.
5. Bolger, T. A., X. Zhao, T. J. Cohen, C.-C. Tsai, and T.-S. Yao. 2007. The neurodegenerative disease protein ataxin-1 antagonizes the neuronal survival function of myocyte enhancer factor-2. J. Biol. Chem. 282:29186-29192.
6. Bollen, M., and M. Beullens. 2002. Signaling by protein phosphatases in the nucleus. Trends Cell. Biol. 12:138-145.
7. Braz, J. C., K. Gregory, A. Pathak, W. Zhao, B. Sahin, R. Klevitsky, T. F. Kimball, J. N. Lorenz, A. C. Nairn, S. B. Liggett, I. Bodi, S. Wang, A. Schwartz, E. G. Lakatta, A. A. DePaoli-Roach, J. Robbins, T. E. Hewett, J. A. Bibb, M. V. Westfall, E. G. Kranias, and J. D. Molkentin. 2004. PKC-α regulates cardiac contractility and propensity toward heart failure. Nat. Med. 10:248-254.
8. Brush, M. H., A. Guardiola, J. H. Connor, T.-P. Yao, and S. Shenolikar. 2004. Deactylase inhibitors disrupt cellular complexes containing protein phosphatases and deacetylases. J. Biol. Chem. 279:7685-7691.
9. Canettieri, G., I. Morantte, E. Guzmán, H. Asahara, S. Herzig, S. D. Anderson, J. R. Yates III, and M. Montminy. 2003. Attenuation of a phosphorylation-dependent activator by an HDAC-PP1 complex. Nat. Struct. Biol. 10:175-181.
10. Carr, A. N., A. G. Schmidt, Y. Suzuki, F. del Monte, Y. Sato, C. Lanner, K. Breeden, S.-H. Jing, P. B. Allen, P. Greengard, A. Yatani, B. D. Hoit, I. L. Grupp, R. J. Hajjar, A. A. DePaoli-Roach, and E. G. Kranias. 2002. Type 1 phosphatase, a negative regulator of cardiac function. Mol. Cell. Biol. 22:4124-4135.
11. Ceulemans, H., and M. Bollen. 2004. Functional diversity of protein phosphatase- 1, a cellular economizer and reset button. Physiol. Rev. 84:1-39.
12. Ceulemans, H., W. Stalmans, and M. Bollen. 2002. Regulator-driven functional diversification of protein phosphatase-1 in eukaryotic evolution. Bioessays 24:371-381. (Pubitemid 34305692)
13. Champion, H. C. 2005. Targeting protein phosphatase 1 in heart failure. Circ. Res. 96:708-710.
14. Cohen, P. T. 2002. Protein phosphatase 1: targeted in many directions. J. Cell Sci. 115:241-256. (Pubitemid 34145174)
15. Cox, D. M., M. Du, M. Marback, C. C. Yang, J. Chan, K. W. M. Siu, and J. C. McDermott. 2003. Phosphorylation motifs regulating the stability and function of myocyte enhancer factor 2A. J. Biol. Chem. 278:15297-15303.
16. Deng, K., D. Z. Ewton, S. E. Mercer, and E. Friedman. 2005. Mirk/dyrk1B decreases the nuclear accumulation of class II histone deacetylases during skeletal muscle differentiation. J. Biol. Chem. 280:4894-4905.
17. Flavell, S. W., C. W. Cowan, T.-K. Kim, P. L. Greer, Y. Lin, S. Paradis, E. C. Griffith, L. S. Hu, C. Chen, and M. E. Greenberg. 2006. Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 311:1008-1012. (Pubitemid 43271729)
18. Gee, C. E., and I. M. Mansuy. 2005. Protein phosphatases and their potential implications in neuroprotective processes. Cell. Mol. Life Sci. 62:1120-1130.
19. Gibbons, J. A., D. C. Weiser, and S. Shenolikar. 2005. Importance of a surface hydrophobic pocket on protein phosphatase-1 catalytic subunit in recognizing cellular regulators. J. Biol. Chem. 280:15903-15911.
20. Gong, X., X. Tang, M. Wiedmann, X. Wang, J. Peng, D. Zheng, L. A. C. Blair, J. Marshall, and Z. Mao. 2003. Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 38:33-46. (Pubitemid 36423351)
21. Grégoire, S., A. M. Tremblay, L. Xiao, Q. Yang, K. Ma, J. Nie, Z. Mao, J. Wu, V. Giguère, and X.-J. Yang. 2006. Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation. J. Biol. Chem. 281:4423-4433.
22. Grégoire, S., L. Xiao, J. Nie, X. Zhang, M. Xu, J. Li, J. Wong, E. Seto, and X.-J. Yang. 2007. Histone deacetylase interacts with and deacetylates myocyte enhancer factor 2. Mol. Cell. Biol. 27:1280-1295.
23. Grozinger, C. M., C. A. Hassig, and S. L. Schreiber. 1999. Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc. Natl. Acad. Sci. USA 96:4868-4873.
24. Grozinger, C. M., and S. L. Schreiber. 2000. Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc. Natl. Acad. Sci. USA 97:7835-7840.
25. Han, J., Y. Jiang, V. V. Kravchenko, and R. J. Ulevitch. 1997. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 386:299. (Pubitemid 27142517)
26. Hédou, G. F., K. Koshibu, M. Farinelli, E. Kilic, C. E. Gee, U. Kilic, K. Baumgärtel, D. M. Hermann, and I. M. Mansuy. 2008. Protein phosphatase 1-dependent bidirectional synaptic plasticity controls ischemic recovery in the adult brain. J. Neurosci. 28:154-162.
27. Kato, Y., V. V. Kravchenko, R. I. Tapping, J. Han, R. J. Ulevitch, and J.-D. Lee. 1997. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J. 16:7054-7066. (Pubitemid 27520805)
28. Kollias, H. D., R. L. S. Perry, Y. Miyake, A. Aziz, and J. C. McDermott. 2006. Smad7 promotes and enhances skeletal muscle differentiation. Mol. Cell. Biol. 26:6248-6260.
29. Lemercier, C., A. Verdel, B. Galloo, S. Curtet, M.-P. Brocard, and S. Khochbin. 2000. mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity. J. Biol. Chem. 275:15594-15599.
30. Li, L., R. Heller-Harrison, M. P. Czech, and E. N. Olson. 1992. Cyclic AMP-dependent protein kinase inhibits the activity of myogenic helix-loop-helix proteins. Mol. Cell. Biol. 12:4478-4485.
31. Lilly, B., B. Zhao, G. Ranganayakulu, B. M. Paterson, R. A. Schulz, and E. N. Olson. 1995. Requirement of MADS domain transcription factor D-MEF2 for muscle formation in Drosophila. Science 267:688-693.
32. Lin, Q., J. Schwarz, C. Bucana, and E. N. Olson. 1997. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276:1404-1407. (Pubitemid 27235406)
33. Liu, S., P. Liu, A. Borras, T. Chatila, and S. H. Speck. 2007. Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated by a novel pathway involving a MEF2 family member. EMBO J. 16:143-153. (Pubitemid 27032857)
34. Liu, Y., W. R. Randall, and M. F. Schneider. 2005. Activity-dependent and -independent nuclear fluxes of HDAC4 mediated by different kinases in adult skeletal muscle. J. Cell Biol. 168:887-897. (Pubitemid 40397003)
35. Lu, J., T. A. McKinsey, R. L. Nicol, and E. N. Olson. 2000. Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc. Natl. Acad. Sci. USA 97:4070-4075.
36. Lu, J., T. A. McKinsey, C.-L. Zhang, and E. N. Olson. 2000. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol. Cell 6:233-244.
37. Mao, Z., A. Bonni, F. Xia, M. Nadal-Vicens, and M. E. Greenberg. 1999. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science 286:785-790. (Pubitemid 129515728)
38. McDermott, J. C., M. C. Cardoso, Y.-T. Yu, V. Andres, D. Leifer, D. Krainc, S. A. Lipton, and B. Nadal-Ginard. 1993. hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors. Mol. Cell. Biol. 13:2564-2577.
39. McKinsey, T. A., C. L. Zhang, and E. N. Olson. 2001. Control of muscle development by dueling HATs and HDACs. Curr. Opin. Genet. Dev. 11:497-504.
40. McKinsey, T. A., C.-L. Zhang, J. Lu, and E. N. Olson. 2000. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408:106-110.
41. Miska, E. A., C. Karlsson, E. Langley, M. J. Nielsen, J. Pines, and T. Kouzarides. 1999. HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J. 18:5099-5107. (Pubitemid 29443811)
42. Molkentin, J. D., B. L. Black, J. F. Martin, and E. N. Olson. 1995. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 83:1125-1136. (Pubitemid 26007804)
43. Morin, S., R. Charron, L. Robataille, and M. Nerner. 2000. GATA-dependent recruitment of MEF2 proteins to target promoters. EMBO J. 19:2046-2055. (Pubitemid 30237580)
44. Morin, S., G. Pozzulo, J. Cross, and M. Nerner. 2005. MEF2-dependent recruitment of the HAND1 transcription factor results in synergistic activation of target promoters. J. Biol. Chem. 280:32272-32278.
45. Munton, R. P., S. Vizi, and I. M. Mansuy. 2004. The role of protein phosphatase- 1 in the modulation of synaptic and structural plasticity. FEBS Lett. 567:121-128. (Pubitemid 38686434)
46. Naya, F. J., B. L. Black, H. Wu, R. Bassel-Duby, J. A. Richardson, J. A. Hill, and E. N. Olson. 2002. Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor. Nat. Med. 8:1303-1309.
47. Naya, F. J., and E. N. Olson. 1999. MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr. Opin. Cell. Biol. 11:683-688.
48. Neumann, J., T. Eschenhagen, L. R. Jones, B. Linck, W. Schmitz, H. Scholz, and N. Zimmermann. 1997. Increased expression of cardiac phosphatases in patients with end-stage heart failure. J. Mol. Cell. Cardiol. 29:265-272.
49. Novitch, B. G., D. B. Spicer, P. S. Kim, W. L. Cheung, and A. B. Lassar. 1999. pRB is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation. Curr. Biol. 9:449-459.
50. Ornatsky, O. I., D. M. Cox, P. Tangirala, J. J. Andreucci, Z. A. Quinn, J. L. Wrana, R. Prywes, Y.-T. Yu, and J. C. McDermott. 1999. Post-translational control of the MEF2A transcriptional regulatory protein. Nucleic Acids Res. 27:2646-2654. (Pubitemid 29306562)
51. Ornatsky, O. I., and J. C. McDermott. 1996. MEF2 protein expression, DNA binding specificity and complex composition, and transcriptional activity in muscle and non-muscle cells. J. Biol. Chem. 271:24927-24933.
52. Passier, R., H. Zeng, N. Frey, F. J. Naya, R. L. Nicol, T. A. McKinsey, P. Overbeek, J. A. Richardson, S. R. Grant, and E. N. Olson. 2000. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J. Clin. Investig. 105:1395-1406.
53. Perry, R. L. S., M. H. Parker, and M. A. Rudnicki. 2001. Activated MEK1 binds the nuclear MyoD transcriptional complex to repress transactivation. Mol. Cell 8:291-301. (Pubitemid 32831547)
54. Shalizi, A., B. Gaudiliere, Z. Yuan, J. Stegmüller, T. Shirogane, Q. Ge, Y. Tan, B. Schulman, J. W. Harper, and A. Bonni. 2006. A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation. Science 311:1012-1017. (Pubitemid 43271730)
55. Smith, P. D., M. P. Mount, R. Shree, S. Callaghan, R. S. Slack, H. Anisman, I. Vincent, X. Wang, Z. Mao, and D. S. Park. 2006. Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2. J. Neurosci. 26:440-447. (Pubitemid 43237108)
56. Tang, X., X. Wang, X. Gong, M. Tong, D. Park, Z. Xia, and Z. Mao. 2005. Cyclin-dependent kinase 5 mediates neurotoxin-induced degradation of the transcription factor myocyte enhancer factor 2. J. Neurosci. 25:4823-4834. (Pubitemid 40664130)
57. van Oort, R. J., E. van Rooij, M. Bourajjaj, J. Schimmel, M. A. Jansen, R. van der Nagel, P. A. Doevendans, M. D. Schneider, C. J. A. van Echteld, and L. J. De Windt. 2006. MEF2 activates a genetic program promoting chamber dilation and contractile dysfunction in calcineurin-induced heart failure. Circulation 114:298-308. (Pubitemid 44297096)
58. Xu, J., N. L. Gong, I. Bodi, B. J. Aronow, P. H. Backx, and J. D. Molkentin. 2006. Myocyte enhancer factors 2A and 2C induce dilated cardiomyopathy in transgenic mice. J. Biol. Chem. 281:9152-9162.
59. Yang, C.-C., O. I. Ornatsky, J. C. McDermott, T. F. Cruz, and C. A. Prody. 1998. Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1. Nucleic Acids Res. 26:4771-4777. (Pubitemid 28466627)
60. 2+-induced release of the transcription factor MEF2. Science 286:790-793.
61. Zhang, C. L., T. A. McKinsey, S. Chang, C. L. Antos, J. A. Hill, and E. N. Olson. 2002. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110:479-488. (Pubitemid 35232291)